Dr. Hall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
833 Saint Vincents Dr Ste 300
Pob Iii
Birmingham, AL 35205Phone+1 205-939-4512Fax+1 205-939-4519
Education & Training
University of TennesseeResidency, Internal Medicine, 1985 - 1987
University of Alabama School of MedicineClass of 1985
Certifications & Licensure
AL State Medical License 1988 - 2025
TN State Medical License 1986 - 1988- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
- Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 180 citationsInhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular PsoriasisHervé Bachelez, Siew Eng Choon, Slaheddine Marrakchi, A. David Burden, Tsen-Fang Tsai
The New England Journal of Medicine. 2019-03-06 - 106 citationsRisankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.Brian G. Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert R. D'Haens
The Lancet. Gastroenterology & Hepatology. 2018-10-01 - 255 citationsRisankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen
Annals of the Rheumatic Diseases. 2018-06-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
